Related Experiment Video
Updated: Aug 18, 2025
08:30
Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
11.3K
Special considerations in GI bleeding in VWD patients
Nicholas L J Chornenki1, Edwin Ocran1, Paula D James1
1Department of Medicine, Queen's University, Kingston, Canada.
Hematology. American Society of Hematology. Education Program
|December 9, 2022
Summary
Gastrointestinal bleeding in von Willebrand disease (VWD) is often linked to angiodysplasia, a condition that is difficult to treat and prone to recurrence. Further research is needed to improve diagnosis and management strategies for VWD patients experiencing GI bleeds.
Area of Science:
- Gastroenterology
- Hematology
- Vascular Biology
Background:
- Gastrointestinal (GI) bleeding is a significant cause of morbidity and mortality in patients with von Willebrand disease (VWD).
- Angiodysplasia is disproportionately represented as a cause of GI bleeding in VWD patients, presenting unique management challenges.
- Von Willebrand factor's role in regulating angiogenesis may explain the clinical association between VWD and angiodysplasia.
Approach:
- This review synthesizes current literature on GI bleeding in VWD, focusing on angiodysplasia.
- Explores the molecular mechanisms linking VWD and angiodysplasia.
- Discusses diagnostic challenges, natural history, recurrence patterns, and therapeutic options for GI bleeding in VWD.
Key Points:
- GI bleeding in VWD is frequently attributed to angiodysplasia, which is challenging to treat and has high recurrence rates.
- The underlying pathophysiology involves von Willebrand factor's influence on angiogenesis.
- Current diagnostic and therapeutic strategies for angiodysplasia-related GI bleeding in VWD are suboptimal.
Conclusions:
- Effective management of GI bleeding in VWD requires a deeper understanding of angiodysplasia pathogenesis.
- Improved diagnostic tools and refined therapeutic approaches, including acute, prophylactic, and adjunctive therapies, are essential for optimizing patient care.
- Further research is critical to address the complexities of GI bleeding in VWD patients, particularly those with angiodysplasia.
Related Concept Videos
01:28Esophageal Varices-II: Clinical Features and Management
118
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
118
01:24Disorders of Hemostasis
1.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.0K
01:24Esophageal Varices-I: Introduction
266
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
266
01:30Venous Thrombosis IV: Nursing Management
19
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
19
01:30Peptic Ulcer Disease I: Introduction
259
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
259
01:29Venous Thrombosis III: Interprofessional Care
16
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
16